Jeffrey Kraws Insider Profile
4 Followers
Jeffrey Kraws, Director at Theriva Biologics, holds 5.53K shares in Flyte Aviation (Ticker: VJET), holds 0.00 shares in Theriva Biologics (Ticker: TOVX).
Jeffrey Kraws's Trading History
You May Also Like
Jeffrey Kraws insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Kraws?
The percentage of profitable transactions made by Jeffrey Kraws is 50%.
What is the average return per transaction made by Jeffrey Kraws?
The average return per transaction made by Jeffrey Kraws is 9.20%.
What stocks does Jeffrey Kraws hold?
Jeffrey Kraws holds: TOVX, VJET stocks.
What was Jeffrey Kraws’s latest transaction?
Jeffrey Kraws’s latest transaction was an Uninformative Buy of $1.09K.
What was Jeffrey Kraws's most profitable transaction?
Jeffrey Kraws’s most profitable transaction was an Informative Sell of VJET stock on June 17, 2019. The return on the trade was 84.10%.
What is Jeffrey Kraws's role in Theriva Biologics?
Jeffrey Kraws's role in Theriva Biologics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
